How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
How AbbVie denied Americans access to fair competition for Humira
Life-Changing Drug Costs Over $3,000 in US, $0 to $225 in Europe
Report pulls no punches in critique of drug patent abuse
Consumer group says drugmakers abuse U.S. patent system to keep prices high
Gaming of U.S. Patent System Is Keeping Drug Prices Sky High
Save America’s Patent System
Addressing Drug Patent Abuse: Restoring The Role Of Inter Partes Review
The COVID-19 Vaccine Patent Waiver Fight Is Far From Over
Weekly Economics Podcast: Vaccine Nationalism